The evolution of lung cancer and impact of subclonal selection in TRACERx.
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
received:
21
10
2021
accepted:
02
02
2023
medline:
21
4
2023
pubmed:
13
4
2023
entrez:
12
4
2023
Statut:
ppublish
Résumé
Lung cancer is the leading cause of cancer-associated mortality worldwide
Identifiants
pubmed: 37046096
doi: 10.1038/s41586-023-05783-5
pii: 10.1038/s41586-023-05783-5
pmc: PMC10115649
doi:
Substances chimiques
ROS1 protein, human
EC 2.7.10.1
RET protein, human
EC 2.7.10.1
ALK protein, human
EC 2.7.10.1
MET protein, human
EC 2.7.10.1
EGFR protein, human
EC 2.7.10.1
Banques de données
ClinicalTrials.gov
['NCT01888601']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
525-533Subventions
Organisme : Cancer Research UK
ID : 25354
Pays : United Kingdom
Organisme : Cancer Research UK
ID : CTRNBC-2022/100001
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 21999
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 24956
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 17786
Pays : United Kingdom
Organisme : Arthritis Research UK
ID : CC2008
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V033077/1
Pays : United Kingdom
Organisme : Arthritis Research UK
ID : CC2041
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 29569
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 30025
Pays : United Kingdom
Investigateurs
John Le Quesne
(J)
Peter Van Loo
(P)
Amrita Bajaj
(A)
Apostolos Nakas
(A)
Azmina Sodha-Ramdeen
(A)
Keng Ang
(K)
Mohamad Tufail
(M)
Mohammed Fiyaz Chowdhry
(MF)
Molly Scotland
(M)
Rebecca Boyles
(R)
Sridhar Rathinam
(S)
Claire Wilson
(C)
Domenic Marrone
(D)
Sean Dulloo
(S)
Gurdeep Matharu
(G)
Jacqui A Shaw
(JA)
Joan Riley
(J)
Lindsay Primrose
(L)
Heather Cheyne
(H)
Mohammed Khalil
(M)
Shirley Richardson
(S)
Tracey Cruickshank
(T)
Kayleigh Gilbert
(K)
Akshay J Patel
(AJ)
Aya Osman
(A)
Christer Lacson
(C)
Gerald Langman
(G)
Helen Shackleford
(H)
Madava Djearaman
(M)
Salma Kadiri
(S)
Angela Leek
(A)
Jack Davies Hodgkinson
(JD)
Nicola Totten
(N)
Angeles Montero
(A)
Elaine Smith
(E)
Eustace Fontaine
(E)
Felice Granato
(F)
Helen Doran
(H)
Juliette Novasio
(J)
Kendadai Rammohan
(K)
Leena Joseph
(L)
Paul Bishop
(P)
Rajesh Shah
(R)
Stuart Moss
(S)
Vijay Joshi
(V)
Philip Crosbie
(P)
Fabio Gomes
(F)
Kate Brown
(K)
Mathew Carter
(M)
Anshuman Chaturvedi
(A)
Lynsey Priest
(L)
Pedro Oliveira
(P)
Colin R Lindsay
(CR)
Alexandra Clipson
(A)
Jonathan Tugwood
(J)
Alastair Kerr
(A)
Dominic G Rothwell
(DG)
Elaine Kilgour
(E)
Hugo J W L Aerts
(HJWL)
Tom L Kaufmann
(TL)
Zoltan Szallasi
(Z)
Judit Kisistok
(J)
Mateo Sokac
(M)
Miklos Diossy
(M)
Jonas Demeulemeester
(J)
Aengus Stewart
(A)
Alastair Magness
(A)
Andrew Rowan
(A)
Angeliki Karamani
(A)
Benny Chain
(B)
Brittany B Campbell
(BB)
Carla Castignani
(C)
Clare E Weeden
(CE)
Corentin Richard
(C)
David R Pearce
(DR)
Despoina Karagianni
(D)
Dina Levi
(D)
Elena Hoxha
(E)
Elizabeth Larose Cadieux
(E)
Emma Nye
(E)
Eva Grönroos
(E)
Felip Gálvez-Cancino
(F)
Foteini Athanasopoulou
(F)
Francisco Gimeno-Valiente
(F)
George Kassiotis
(G)
Georgia Stavrou
(G)
Gerasimos Mastrokalos
(G)
Haoran Zhai
(H)
Helen L Lowe
(HL)
Ignacio Matos
(I)
Jacki Goldman
(J)
James L Reading
(JL)
Jayant K Rane
(JK)
Jie Min Lam
(JM)
John A Hartley
(JA)
Katey S S Enfield
(KSS)
Kayalvizhi Selvaraju
(K)
Kevin Litchfield
(K)
Kevin W Ng
(KW)
Kezhong Chen
(K)
Krijn Dijkstra
(K)
Krupa Thakkar
(K)
Leah Ensell
(L)
Mansi Shah
(M)
Marcos Vasquez
(M)
Maria Litovchenko
(M)
Mariana Werner Sunderland
(M)
Michelle Leung
(M)
Mickael Escudero
(M)
Miljana Tanić
(M)
Monica Sivakumar
(M)
Nnennaya Kanu
(N)
Olga Chervova
(O)
Olivia Lucas
(O)
Othman Al-Sawaf
(O)
Philip Hobson
(P)
Piotr Pawlik
(P)
Richard Kevin Stone
(RK)
Robert E Hynds
(RE)
Roberto Vendramin
(R)
Sadegh Saghafinia
(S)
Saioa López
(S)
Samuel Gamble
(S)
Seng Kuong Anakin Ung
(SKA)
Sharon Vanloo
(S)
Stefan Boeing
(S)
Stephan Beck
(S)
Supreet Kaur Bola
(SK)
Tamara Denner
(T)
Thanos P Mourikis
(TP)
Victoria Spanswick
(V)
Vittorio Barbè
(V)
Wei-Ting Lu
(WT)
William Hill
(W)
Yin Wu
(Y)
Yutaka Naito
(Y)
Zoe Ramsden
(Z)
Catarina Veiga
(C)
Gary Royle
(G)
Charles-Antoine Collins-Fekete
(CA)
Francesco Fraioli
(F)
Paul Ashford
(P)
Tristan Clark
(T)
Elaine Borg
(E)
James Wilson
(J)
Alexander James Procter
(AJ)
Asia Ahmed
(A)
Magali N Taylor
(MN)
Arjun Nair
(A)
Davide Patrini
(D)
Emilie Martinoni Hoogenboom
(E)
Fleur Monk
(F)
James W Holding
(JW)
Junaid Choudhary
(J)
Kunal Bhakhri
(K)
Marco Scarci
(M)
Martin Hayward
(M)
Nikolaos Panagiotopoulos
(N)
Pat Gorman
(P)
Reena Khiroya
(R)
Robert Cm Stephens
(RC)
Yien Ning Sophia Wong
(YNS)
Steve Bandula
(S)
Abigail Sharp
(A)
Sean Smith
(S)
Nicole Gower
(N)
Harjot Kaur Dhanda
(HK)
Kitty Chan
(K)
Camilla Pilotti
(C)
Rachel Leslie
(R)
Anca Grapa
(A)
Hanyun Zhang
(H)
Khalid AbdulJabbar
(K)
Xiaoxi Pan
(X)
Yinyin Yuan
(Y)
David Chuter
(D)
Mairead MacKenzie
(M)
Serena Chee
(S)
Aiman Alzetani
(A)
Lydia Scarlett
(L)
Jennifer Richards
(J)
Papawadee Ingram
(P)
Silvia Austin
(S)
Paulo De Sousa
(P)
Simon Jordan
(S)
Alexandra Rice
(A)
Hilgardt Raubenheimer
(H)
Harshil Bhayani
(H)
Lyn Ambrose
(L)
Anand Devaraj
(A)
Hema Chavan
(H)
Sofina Begum
(S)
Silviu I Buderi
(SI)
Daniel Kaniu
(D)
Mpho Malima
(M)
Sarah Booth
(S)
Nadia Fernandes
(N)
Pratibha Shah
(P)
Chiara Proli
(C)
Sarah Danson
(S)
Lily Robinson
(L)
Craig Dick
(C)
Alan Kirk
(A)
Mo Asif
(M)
Rocco Bilancia
(R)
Nikos Kostoulas
(N)
Mathew Thomas
(M)
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2023. The Author(s).
Références
Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).
pubmed: 33538338
doi: 10.3322/caac.21660
Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883–892 (2012).
pubmed: 22397650
doi: 10.1056/NEJMoa1113205
pmcid: 4878653
Jamal-Hanjani, M. et al. Tracking the evolution of non–small-cell lung cancer. N. Engl. J. Med. 376, 2109–2121 (2017).
pubmed: 28445112
doi: 10.1056/NEJMoa1616288
Turajlic, S. et al. Deterministic evolutionary trajectories influence primary tumor growth: TRACERx Renal. Cell 173, 595–610.e11 (2018).
pubmed: 29656894
doi: 10.1016/j.cell.2018.03.043
pmcid: 5938372
Ciriello, G. et al. Emerging landscape of oncogenic signatures across human cancers. Nat. Genet. 45, 1127–1133 (2013).
pubmed: 24071851
doi: 10.1038/ng.2762
pmcid: 4320046
Williams, M. J., Werner, B., Barnes, C. P., Graham, T. A. & Sottoriva, A. Identification of neutral tumor evolution across cancer types. Nat. Genet. 48, 238–244 (2016).
pubmed: 26780609
doi: 10.1038/ng.3489
pmcid: 4934603
Reiter, J. G. et al. Minimal functional driver gene heterogeneity among untreated metastases. Science 361, 1033–1037 (2018).
pubmed: 30190408
doi: 10.1126/science.aat7171
pmcid: 6329287
Reiter, J. G. et al. An analysis of genetic heterogeneity in untreated cancers. Nat. Rev. Cancer 19, 639–650 (2019).
pubmed: 31455892
doi: 10.1038/s41568-019-0185-x
pmcid: 6816333
Al Bakir, M. et al. The evolution of non-small lung cancer metastases in TRACERx. Nature https://doi.org/10.1038/s41586-023-05729-x (2023).
Rekhtman, N. et al. Unsuspected collision of synchronous lung adenocarcinomas: a potential cause of aberrant driver mutation profiles. J. Thorac. Oncol. 9, e1–e3 (2014).
pubmed: 24346104
doi: 10.1097/JTO.0b013e3182a471c3
Grigoriadis, K. et al. CONIPHER: a computational framework for scalable phylogenetic reconstruction with error correction. Protoc. Exch. https://doi.org/10.21203/rs.3.pex-2158/v1 (2023).
Rahman, N. Realizing the promise of cancer predisposition genes. Nature 505, 302–308 (2014).
pubmed: 24429628
doi: 10.1038/nature12981
pmcid: 4975511
Zaccaria, S. & Raphael, B. J. Accurate quantification of copy-number aberrations and whole-genome duplications in multi-sample tumor sequencing data. Nat. Commun. 11, 4301 (2020).
pubmed: 32879317
doi: 10.1038/s41467-020-17967-y
pmcid: 7468132
Lawson, A. R. J. et al. Extensive heterogeneity in somatic mutation and selection in the human bladder. Science 370, 75–82 (2020).
pubmed: 33004514
doi: 10.1126/science.aba8347
Pirie, K. et al. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet 381, 133–141 (2013).
pubmed: 23107252
doi: 10.1016/S0140-6736(12)61720-6
pmcid: 3547248
Byers, T. E., Vena, J. E. & Rzepka, T. F. Predilection of lung cancer for the upper lobes: an epidemiologic inquiry. J. Natl Cancer Inst. 72, 1271–1275 (1984).
pubmed: 6328090
Lee, B. W., Wain, J. C., Kelsey, K. T., Wiencke, J. K. & Christiani, D. C. Association between diet and lung cancer location. Am. J. Respir. Crit. Care Med. 158, 1197–1203 (1998).
pubmed: 9769282
doi: 10.1164/ajrccm.158.4.9804089
Martincorena, I. et al. Universal patterns of selection in cancer and somatic tissues. Cell 171, 1029–1041.e21 (2017).
pubmed: 29056346
doi: 10.1016/j.cell.2017.09.042
pmcid: 5720395
Watkins, T. B. K. et al. Pervasive chromosomal instability and karyotype order in tumour evolution. Nature 587, 126–132 (2020).
pubmed: 32879494
doi: 10.1038/s41586-020-2698-6
pmcid: 7611706
Mina, M. et al. Conditional selection of genomic alterations dictates cancer evolution and oncogenic dependencies. Cancer Cell 32, 155–168.e6 (2017).
pubmed: 28756993
doi: 10.1016/j.ccell.2017.06.010
de Bruin, E. C. et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science 346, 251–256 (2014).
pubmed: 25301630
doi: 10.1126/science.1253462
pmcid: 4636050
Cross, W. et al. The evolutionary landscape of colorectal tumorigenesis. Nat. Ecol. Evol. 2, 1661–1672 (2018).
pubmed: 30177804
doi: 10.1038/s41559-018-0642-z
pmcid: 6152905
Bielski, C. M. et al. Genome doubling shapes the evolution and prognosis of advanced cancers. Nat. Genet. 50, 1189–1195 (2018).
pubmed: 30013179
doi: 10.1038/s41588-018-0165-1
pmcid: 6072608
Dewhurst, S. M. et al. Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution. Cancer Discov. 4, 175–185 (2014).
pubmed: 24436049
doi: 10.1158/2159-8290.CD-13-0285
pmcid: 4293454
Satas, G. et al. DeCiFering the elusive cancer cell fraction in tumor heterogeneity and evolution. Cell Syst. https://doi.org/10.1016/j.cels.2021.07.006 (2023).
Martínez-Ruiz, C. et al. Genomic–transcriptomic evolution in lung cancer and metastasis. Nature https://doi.org/10.1038/s41586-023-05706-4 (2023).
Tarabichi, M. et al. Neutral tumor evolution? Nat. Genet. 50, 1630–1633 (2018).
pubmed: 30374075
doi: 10.1038/s41588-018-0258-x
pmcid: 6548558
Heide, T. et al. Reply to ‘Neutral tumor evolution?’. Nat. Genet. 50, 1633–1637 (2018).
pubmed: 30374073
doi: 10.1038/s41588-018-0256-z
Bailey, M. H. et al. Comprehensive characterization of cancer driver genes and mutations. Cell 173, 371–385.e18 (2018).
pubmed: 29625053
doi: 10.1016/j.cell.2018.02.060
pmcid: 6029450
Dentro, S. C. et al. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. Cell 184, 2239–2254.e39 (2021).
pubmed: 33831375
doi: 10.1016/j.cell.2021.03.009
pmcid: 8054914
Gerstung, M. et al. The evolutionary history of 2,658 cancers. Nature 578, 122–128 (2020).
pubmed: 32025013
doi: 10.1038/s41586-019-1907-7
pmcid: 7054212
Sottoriva, A. et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc. Natl Acad. Sci. USA 110, 4009–4014 (2013).
pubmed: 23412337
doi: 10.1073/pnas.1219747110
pmcid: 3593922
Shain, A. H. et al. The genetic evolution of metastatic uveal melanoma. Nat. Genet. 51, 1123–1130 (2019).
pubmed: 31253977
doi: 10.1038/s41588-019-0440-9
pmcid: 6632071
Murugaesu, N. et al. Tracking the genomic evolution of esophageal adenocarcinoma through neoadjuvant chemotherapy. Cancer Discov. 5, 821–831 (2015).
pubmed: 26003801
doi: 10.1158/2159-8290.CD-15-0412
pmcid: 4529488
Zhang, J. et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science 346, 256–259 (2014).
pubmed: 25301631
doi: 10.1126/science.1256930
pmcid: 4354858
Yates, L. R. et al. Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat. Med. 21, 751–759 (2015).
pubmed: 26099045
doi: 10.1038/nm.3886
pmcid: 4500826
Turajlic, S. et al. Tracking cancer evolution reveals constrained routes to metastases: TRACERx Renal. Cell 173, 581–594.e12 (2018).
pubmed: 29656895
doi: 10.1016/j.cell.2018.03.057
pmcid: 5938365
Mitchell, T. J. et al. Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx Renal. Cell 173, 611–623.e17 (2018).
pubmed: 29656891
doi: 10.1016/j.cell.2018.02.020
pmcid: 5927631
Yoshida, K. et al. Tobacco smoking and somatic mutations in human bronchial epithelium. Nature 578, 266–272 (2020).
pubmed: 31996850
doi: 10.1038/s41586-020-1961-1
pmcid: 7021511
Berenblum, I. & Shubik, P. A new, quantitative, approach to the study of the stages of chemical carcinogenesis in the mouse’s skin. Br. J. Cancer 1, 383–391 (1947).
pubmed: 18906316
doi: 10.1038/bjc.1947.36
pmcid: 2007527
Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884–i890 (2018).
pubmed: 30423086
doi: 10.1093/bioinformatics/bty560
pmcid: 6129281
Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 25, 1754–1760 (2009).
pubmed: 19451168
doi: 10.1093/bioinformatics/btp324
pmcid: 2705234
Tarasov, A., Vilella, A. J., Cuppen, E., Nijman, I. J. & Prins, P. Sambamba: fast processing of NGS alignment formats. Bioinformatics 31, 2032–2034 (2015).
pubmed: 25697820
doi: 10.1093/bioinformatics/btv098
pmcid: 4765878
McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297–1303 (2010).
pubmed: 20644199
doi: 10.1101/gr.107524.110
pmcid: 2928508
Li, H. et al. The sequence alignment/map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
pubmed: 19505943
doi: 10.1093/bioinformatics/btp352
pmcid: 2723002
Bergmann, E. A., Chen, B.-J., Arora, K., Vacic, V. & Zody, M. C. Conpair: concordance and contamination estimator for matched tumor–normal pairs. Bioinformatics 32, 3196–3198 (2016).
pubmed: 27354699
doi: 10.1093/bioinformatics/btw389
pmcid: 5048070
Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568–576 (2012).
pubmed: 22300766
doi: 10.1101/gr.129684.111
pmcid: 3290792
Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213–219 (2013).
pubmed: 23396013
doi: 10.1038/nbt.2514
pmcid: 3833702
Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).
pubmed: 20601685
doi: 10.1093/nar/gkq603
pmcid: 2938201
Tate, J. G. et al. COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res. 47, D941–D947 (2019).
pubmed: 30371878
doi: 10.1093/nar/gky1015
Rimmer, A. et al. Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications. Nat. Genet. 46, 912–918 (2014).
pubmed: 25017105
doi: 10.1038/ng.3036
pmcid: 4753679
Cheng, J. et al. Single-cell copy number variation detection. Genome Biol. 12, R80 (2011).
pubmed: 21854607
doi: 10.1186/gb-2011-12-8-r80
pmcid: 3245619
Van Loo, P. et al. Allele-specific copy number analysis of tumors. Proc. Natl Acad. Sci. USA 107, 16910–16915 (2010).
pubmed: 20837533
doi: 10.1073/pnas.1009843107
pmcid: 2947907
Favero, F. et al. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data. Ann. Oncol. 26, 64–70 (2015).
pubmed: 25319062
doi: 10.1093/annonc/mdu479
Burrell, R. A. et al. Replication stress links structural and numerical cancer chromosomal instability. Nature 494, 492–496 (2013).
pubmed: 23446422
doi: 10.1038/nature11935
pmcid: 4636055
Costello, M. et al. Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation. Nucleic Acids Res. 41, e67 (2013).
pubmed: 23303777
doi: 10.1093/nar/gks1443
pmcid: 3616734
Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94–101 (2020).
pubmed: 32025018
doi: 10.1038/s41586-020-1943-3
pmcid: 7054213
Rosenthal, R., McGranahan, N., Herrero, J., Taylor, B. S. & Swanton, C. DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. Genome Biol. 17, 31 (2016).
pubmed: 26899170
doi: 10.1186/s13059-016-0893-4
pmcid: 4762164
Teh, Y. W., Jordan, M. I., Beal, M. J. & Blei, D. M. Hierarchical dirichlet processes. J. Am. Stat. Assoc. 101, 1566–1581 (2006).
doi: 10.1198/016214506000000302
Degasperi, A. et al. Substitution mutational signatures in whole-genome-sequenced cancers in the UK population. Science 376, abl9283 (2022).
doi: 10.1126/science.abl9283
McGranahan, N. et al. Clonal status of actionable driver events and the timing of mutational processes in cancer evolution. Sci. Transl. Med. 7, 283ra54 (2015).
pubmed: 25877892
doi: 10.1126/scitranslmed.aaa1408
pmcid: 4636056
Roth, A. et al. PyClone: statistical inference of clonal population structure in cancer. Nat. Methods 11, 396–398 (2014).
pubmed: 24633410
doi: 10.1038/nmeth.2883
pmcid: 4864026
Myers, M. A., Satas, G. & Raphael, B. J. CALDER: inferring phylogenetic trees from longitudinal tumor samples. Cell Syst. 8, 514–522.e5 (2019).
pubmed: 31229560
doi: 10.1016/j.cels.2019.05.010
pmcid: 7263382
Deshwar, A. G. et al. PhyloWGS: reconstructing subclonal composition and evolution from whole-genome sequencing of tumors. Genome Biol. 16, 35 (2015).
pubmed: 25786235
doi: 10.1186/s13059-015-0602-8
pmcid: 4359439
El-Kebir, M., Oesper, L., Acheson-Field, H. & Raphael, B. J. Reconstruction of clonal trees and tumor composition from multi-sample sequencing data. Bioinformatics 31, i62–i70 (2015).
pubmed: 26072510
doi: 10.1093/bioinformatics/btv261
pmcid: 4542783
Satas, G. & Raphael, B. J. Tumor phylogeny inference using tree-constrained importance sampling. Bioinformatics 33, i152–i160 (2017).
pubmed: 28882002
doi: 10.1093/bioinformatics/btx270
pmcid: 5870673
El-Kebir, M. et al. Complexity and algorithms for copy-number evolution problems. Algorithms Mol. Biol. 12, 13 (2017).
pubmed: 28515774
doi: 10.1186/s13015-017-0103-2
pmcid: 5433102
Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413–421 (2012).
pubmed: 22544022
doi: 10.1038/nbt.2203
pmcid: 4383288
Forbes, S. A. et al. COSMIC: exploring the world’s knowledge of somatic mutations in human cancer. Nucleic Acids Res. 43, D805–D811 (2015).
pubmed: 25355519
doi: 10.1093/nar/gku1075
Lawrence, M. S. et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495–501 (2014).
pubmed: 24390350
doi: 10.1038/nature12912
pmcid: 4048962
Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature 489, 519–525 (2012).
doi: 10.1038/nature11404
Collisson, E. et al. Comprehensive molecular profiling of lung adenocarcinoma: The Cancer Genome Atlas Research Network. Nature 511, 543–550 (2014).
doi: 10.1038/nature13385
Campbell, J. D. et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat. Genet. 48, 607–616 (2016).
pubmed: 27158780
doi: 10.1038/ng.3564
pmcid: 4884143
Kumar, P., Henikoff, S. & Ng, P. C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073–1081 (2009).
pubmed: 19561590
doi: 10.1038/nprot.2009.86
Adzhubei, I., Jordan, D. M. & Sunyaev, S. R. Predicting functional effect of human missense mutations using PolyPhen-2. Curr. Protoc. Hum. Genet. https://doi.org/10.1002/0471142905.hg0720s76 (2013).
Schwarz, J. M., Rödelsperger, C., Schuelke, M. & Seelow, D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat. Methods 7, 575–576 (2010).
pubmed: 20676075
doi: 10.1038/nmeth0810-575
Berger, A. H. et al. High-throughput phenotyping of lung cancer somatic mutations. Cancer Cell 30, 214–228 (2016).
pubmed: 27478040
doi: 10.1016/j.ccell.2016.06.022
pmcid: 5003022
Sanchez-Vega, F. et al. Oncogenic signaling pathways in The Cancer Genome Atlas. Cell 173, 321–337.e10 (2018).
pubmed: 29625050
doi: 10.1016/j.cell.2018.03.035
pmcid: 6070353
Canisius, S., Martens, J. W. M. & Wessels, L. F. A. A novel independence test for somatic alterations in cancer shows that biology drives mutual exclusivity but chance explains most co-occurrence. Genome Biol. 17, 261 (2016).
pubmed: 27986087
doi: 10.1186/s13059-016-1114-x
pmcid: 5162102
Frankell, A. M., Colliver, E., Mcgranahan, N. & Swanton, C. cloneMap: a R package to visualise clonal heterogeneity. Preprint at bioRxiv https://doi.org/10.1101/2022.07.26.501523 (2022).
Broad Institute TCGA Genome Data Analysis Center (2016): SNP6 Copy number analysis (GISTIC2) (Broad Institute of MIT and Harvard, 2016).
Royston, P. & Parmar, M. K. B. Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome. BMC Med. Res. Methodol. 13, 152 (2013).
pubmed: 24314264
doi: 10.1186/1471-2288-13-152
pmcid: 3922847
Uno, H. et al. Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis. J. Clin. Oncol. 32, 2380–2385 (2014).
pubmed: 24982461
doi: 10.1200/JCO.2014.55.2208
pmcid: 4105489
Liang, F., Zhang, S., Wang, Q. & Li, W. Treatment effects measured by restricted mean survival time in trials of immune checkpoint inhibitors for cancer. Ann. Oncol. 29, 1320–1324 (2018).
pubmed: 29788167
doi: 10.1093/annonc/mdy075